Whole-genome single nucleotide polymorphism array analysis is complementary to classical cytogenetic analysis in the evaluation of lymphoid proliferations.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Clinical Pathology

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1309/AJCPRHGHT28DUWLAPMID 24436273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?

  2013cited by this paper
• Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.

  2013cited by this paper
• Clonal heterogeneity of mantle cell lymphoma revealed by array comparative genomic hybridization

  2013cited by this paper
• Array-based karyotyping in plasma cell neoplasia after plasma cell enrichment increases detection of genomic aberrations.

  2012cited by this paper
• Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.

  2012cited by this paper
• Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma.

  2012cited by this paper
• Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how?

  2012cited by this paper
• Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays.

  2011cited by this paper
• Genome-Wide Mapping of Copy Number Variation in Humans: Comparative Analysis of High Resolution Array Platforms

  2011cited by this paper
• Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.

  2011cited by this paper
• Microarray‐based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia

  2011cited by this paper
• Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia

  2011cited by this paper
• Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy.

  2010cited by this paper
• High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus

  2010cited by this paper
• IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL

  2010cited by this paper
• Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.

  2010influential reference
• SNP array analysis in hematologic malignancies: avoiding false discoveries.

  2010cited by this paper
• Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.

  2010cited by this paper
• Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

  2010cited by this paper
• High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy‐neutral loss of heterozygosity and copy number alterations that target single genes

  2010influential reference
• High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations

  2010cited by this paper
• Genomic profiling of high-risk acute lymphoblastic leukemia

  2010cited by this paper
• Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

  2010cited by this paper
• Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status

  2009cited by this paper
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

  2009cited by this paper
• Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.

  2009cited by this paper
• Acquired mutations in TET2 are common in myelodysplastic syndromes

  2009cited by this paper
• New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.

  2009cited by this paper
• FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib

  2009cited by this paper
• Application of array‐based whole genome scanning technologies as a cytogenetic tool in haematological malignancies

  2009cited by this paper
• Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia

  2008cited by this paper
• Whole genome scanning as a cytogenetic tool in hematologic malignancies.

  2008cited by this paper
• Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.

  2008cited by this paper
• Single nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS

  2007cited by this paper
• Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.

  2007cited by this paper
• High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression

  2007cited by this paper
• Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.

  2007cited by this paper
• Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.

  2007cited by this paper
• Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma

  2007cited by this paper
• Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.

  2007cited by this paper
• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

  2007cited by this paper
• Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.

  2007cited by this paper
• Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies.

  2004cited by this paper
• Detection of large-scale variation in the human genome

  2004cited by this paper
• Visualizing DNA domains and sequences by microscopy: a fifty-year history of molecular cytogenetics.

  2003cited by this paper
• Visualizing DNA domains and sequences by microscopy: a fifty-year history of molecular cytogenetics.

  2003cited by this paper
• Clinical laboratory medicine

  1994cited by this paper
• Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations.

  1991cited by this paper

• Identification of a cryptic submicroscopic deletion using a combination of fluorescence in situ hybridization and array comparative genomic hybridization in a t(3;5)(q25;q35)-positive acute myeloid leukemia patient

  2020cites this paper
• Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay

  2019cites this paper
• Diagnostic molecular techniques in haematology: recent advances.

  2018cites this paper
• Prenatal diagnosis of sex chromosomal inversion, translocation and deletion

  2017cites this paper
• Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes

  2015cites this paper
• Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

  2015cites this paper
• Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes

  2014cites this paper